melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Melanoma in situ of upper limb, including shoulder
DOID EFO Endpoint Browser PheWeb
CD2_INSITU_MELANOMA_UPPERLIMB
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
305 |
4. Check minimum number of eventsNone |
305 |
5. Include endpointsNone |
305 |
6. Filter based on genotype QC (FinnGen only) |
280 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ regionis deltoideae
Melanoma in situ of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 280 | 165 | 115 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | 69.03 | 67.72 | 70.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 289
- Matched controls
- 2890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
209.3
307.7
184
24
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
4503599627370496.0
307.7
288
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
49.2
98.9
59
15
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
227.1
94.6
93
6
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
13.4
82.0
91
96
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
15.6
80.9
79
68
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.9
74.3
109
166
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
14.4
71.2
72
65
L57.0
ICD-10 Finland
Actinic keratosis
6.8
53.3
114
253
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
8.2
53.2
85
139
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.1
52.6
149
428
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.1
38.3
81
173
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
14.3
33.7
32
25
S82
ICPC
Naevus/mole
4.9
32.9
94
258
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
9.6
30.3
38
45
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
74.1
29.6
33
5
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
11.9
29.2
31
29
TQW99
NOMESCO Finland
Other minor procedure on skin
6.5
28.7
52
94
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.5
28.5
33
35
ZZR00
NOMESCO Finland
Flap of skin
10.7
27.3
31
32
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
5.2
27.0
65
153
S18
ICPC
Laceration/cut
3.8
24.9
205
1124
D22
ICD-10 Finland
Melanocytic naevi
7.2
23.2
37
58
ZXC50
NOMESCO Finland
Cryotherapy
7.4
22.2
34
51
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
8.1
22.1
31
42
TQW40, ,
SPAT
4.1
19.6
63
184
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
28.4
19.5
26
10
XQ848
NOMESCO Finland
Dermatological photography
7.8
19.4
28
39
L82
ICD-10 Finland
Seborrhoeic keratosis
3.3
19.3
103
419
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
37.2
19.2
24
7
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
4.6
18.6
50
127
D06BB10
ATC
imiquimod; topical
5.1
17.4
39
85
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
6.1
17.4
32
58
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
13.9
17.1
29
23
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
95.7
16.8
18
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
180.0
16.7
17
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
90.1
15.7
17
*
SPAT1153
SPAT
Removal of sutures
2.7
15.6
134
693
D03.5
ICD-10 Finland
Melanoma in situ of trunk
38.2
14.6
18
5
XQ845
NOMESCO Finland
Dermatoscopy
11.8
13.8
25
23
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
5.7
13.5
26
49
S77
ICPC
Malignant neoplasm of skin
16.1
13.3
21
14
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
23.9
13.1
18
8
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
52.5
13.0
15
*
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
12.6
12
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
67.8
11.7
13
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
24.1
11.7
16
7
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
114.0
10.5
11
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
33.9
10.4
13
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
24.4
10.3
14
6
PJA12
NOMESCO Finland
Sentinel node biopsy
3.2
10.2
44
153
S29
ICPC
Skin symptom/complaint other
2.4
9.7
84
420
C43
ICD-10 Finland
Malignant melanoma of skin
31.2
9.5
12
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
12.1
8.7
15
13
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
20.8
8.5
12
6
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
+∞
8.4
8
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
15.0
8.3
13
9
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
6.5
7.7
19
31
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
25.8
7.6
10
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
30.8
7.2
9
*
L01BC02
ATC
fluorouracil; systemic, topical
20.6
7.2
10
5
S21
ICPC
Skin texture symptom/complaint
2.3
7.1
61
300
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
14.2
6.9
11
8
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
6.4
6.9
17
28
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
41.0
6.8
8
*
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
4.2
6.7
18
45
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
12.6
6.6
11
9
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
5.6
6.6
18
34
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
71.4
6.5
7
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
14.7
6.4
10
7
ZXC15
NOMESCO Finland
Use of photodynamic technique
6.8
6.4
15
23
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
8.4
6.4
13
16
127
Kela drug reimbursment
Transplant complication
11.4
6.3
11
10
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
11.4
6.3
11
10
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
7.3
6.3
14
20
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
6.3
208
1633
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.6
6.3
17
32
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
3.3
6.0
23
74
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
193
1409
2.11
8.13
8.6
7.3
1.22
1.21
mmol/l
0.72
168
1215
48
215
2.48
6.90
4.0
3.4
88.02
79.73
ng/l
0.20
35
186
278
2453
4.50
6.66
6.6
6.2
2.68
2.62
mmol/l
0.52
244
2246
274
2401
3.72
6.52
5.9
5.3
1.51
1.49
mmol/l
0.33
238
2194
274
2411
3.63
6.26
5.9
5.4
4.65
4.56
mmol/l
0.66
241
2213
280
2561
4.00
5.94
15.1
12.6
24.12
24.54
u/l
0.21
271
2485
272
2397
3.29
5.91
6.2
5.5
5.79
6.01
mmol/l
2.62
231
2187
173
1296
1.83
5.84
8.5
6.5
1.22
1.21
mmol/l
0.49
160
1193
270
2377
3.07
5.74
21.6
17.6
76.08
76.93
ml/min/173m2
0.28
263
2216
162
1204
1.79
5.48
3.0
2.5
82.74
78.96
nmol/l
1.13
138
1076
137
983
1.75
5.13
3.7
3.5
2.33
2.35
mmol/l
1.71
111
892
266
2353
2.64
5.04
7.5
6.9
38.43
39.77
mmol/mol
2.53
233
2199
230
1932
1.93
4.88
5.3
4.4
11.23
12.94
mm/h
1.11
208
1792
141
1061
1.64
4.15
2.0
2.0
1.23
1.33
mmol/l
1.13
105
875
74
472
1.76
4.02
3.9
3.4
0.77
0.79
ug/l
0.07
47
306
257
2292
2.10
3.90
7.5
5.5
1.80
1.97
mu/l
1.81
235
2088
100
700
1.66
3.85
3.6
2.9
343.03
345.50
umol/l
0.10
91
610
17
62
2.85
3.65
2.4
1.3
—
—
—
0
0
18
70
2.68
3.45
1.9
1.5
—
—
—
0
0
274
2531
2.59
3.40
25.5
21.3
3.99
3.99
mmol/l
0.05
269
2480
256
2305
1.97
3.39
5.1
4.5
1.27
1.28
mmol/l
0.08
217
2084
179
1480
1.55
3.20
9.3
10.0
4.18
4.16
e9/l
0.03
145
1288
53
334
1.72
2.96
6.1
5.1
33.21
32.64
%
0.14
28
210
201
1728
1.54
2.82
5.3
5.1
19.00
1639.95
e6/l
—
5
37
227
2009
1.61
2.77
10.3
8.3
75.00
81.38
u/l
2.02
210
1898
264
2438
1.96
2.69
20.3
17.6
21.36
24.31
mg/l
0.95
230
2043
67
461
1.59
2.66
4.8
3.3
0.84
0.81
mmol/l
0.87
60
437
164
1372
1.45
2.49
3.0
2.8
—
—
—
0
0
149
1226
1.44
2.46
2.4
2.2
95.64
96.38
pmol/l
0.05
67
604
15
64
2.42
2.43
1.5
1.6
—
—
—
0
0
52
350
1.59
2.26
1.8
1.5
—
—
—
0
0
67
478
1.52
2.26
1.4
1.3
23.47
31.67
iu/ml
0.50
15
157
148
1230
1.42
2.25
3.3
2.9
—
—
estimate
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
10
5.07
2.08
1.6
2.1
143.80
126.60
%
—
5
10
148
1242
1.39
2.07
5.4
4.7
35.39
35.28
g/l
0.09
134
1173
7
20
3.56
2.07
1.4
1.5
20.29
13.95
u/l
—
7
20
11
45
2.50
1.95
1.4
1.4
—
—
—
0
0
214
1925
1.43
1.91
6.1
4.3
15.10
14.92
pmol/l
0.48
188
1744
9
34
2.70
1.88
2.4
1.3
—
—
—
0
0
81
624
1.41
1.83
5.4
5.0
22.95
21.86
%
0.23
41
309
84
653
1.40
1.80
3.4
2.4
—
—
—
0
0
17
88
1.99
1.79
2.5
3.0
—
—
—
0
0
106
859
1.37
1.77
1.9
1.8
23.97
21.51
nmol/l
0.63
79
708
6
19
3.20
1.67
1.3
1.2
11.17
13.05
u/l
—
6
19
5
14
3.61
1.62
2.8
1.6
105.00
106.57
%
—
5
14
182
1617
1.34
1.59
4.0
3.3
45.65
48.95
u/l
0.27
166
1515
89
712
1.36
1.59
2.5
2.2
2.84
3.02
mg/l
0.29
66
617
13
64
2.08
1.56
1.4
1.3
—
—
—
0
0
57
424
1.43
1.55
1.4
1.3
11.40
10.94
u/ml
0.02
17
157
105
865
1.34
1.54
2.6
2.0
232.23
192.97
u/l
0.22
97
813
13
65
2.05
1.51
1.8
1.2
—
—
—
0
0
16
87
1.89
1.49
1.9
1.8
—
—
—
0
0
17
95
1.84
1.46
1.9
2.0
—
—
—
0
0
6
22
2.76
1.44
2.3
1.1
—
—
—
0
0
135
1162
1.30
1.43
3.9
3.0
170.94
126.75
ug/l
1.12
121
1071
10
46
2.22
1.41
2.2
1.6
—
—
—
0
0
6
23
2.64
1.37
1.7
1.3
358.33
338.27
u/l
—
6
23
6
23
2.64
1.37
3.2
1.7
—
—
—
0
0
23
144
1.65
1.37
1.4
2.1
1.22
1.50
g/l
0.66
18
128
5
17
2.97
1.36
1.6
1.0
—
—
—
0
0
27
177
1.58
1.34
2.0
1.8
—
—
—
0
0
96
796
1.31
1.32
7.2
5.8
8.37
2.40
ug/l
0.45
85
712
6
24
2.53
1.31
1.3
1.0
—
—
—
0
0
57
444
1.35
1.20
3.6
2.4
2.19
2.27
g/l
0.58
52
404
150
1330
1.27
1.19
24.6
14.4
1.40
1.26
inr
1.89
127
1092
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
79
1.81
1.19
5.7
2.5
0.29
0.37
iu/ml
—
9
46
13
72
1.84
1.17
2.2
1.5
—
—
—
0
0
94
793
1.27
1.11
4.0
3.2
0.97
0.50
e6/l
0.28
68
577
5
21
2.40
1.09
1.2
1.1
—
—
—
0
0
54
425
1.33
1.07
3.8
2.4
23.00
22.26
%
0.17
49
393
60
480
1.32
1.06
3.6
2.4
12.58
12.89
umol/l
0.13
53
442
11
60
1.87
1.04
6.4
2.5
10.49
8.37
pmol/l
0.24
11
60
22
147
1.54
1.04
3.0
3.0
2.50
1.87
mmol/l
0.20
13
109
7
35
2.02
1.00
2.3
1.4
—
—
—
0
0
11
62
1.80
0.95
1.2
1.3
—
—
—
0
0
58
469
1.30
0.95
3.4
3.1
2.90
2.50
e6/l
0.15
28
225
60
489
1.29
0.93
3.5
3.0
0.86
1.00
e6/l
0.21
30
241
40
308
1.35
0.92
5.4
7.7
—
—
—
0
0
50
618
0.77
0.92
4.9
4.4
1.02
1.02
kg/l
0.21
37
410
6
29
2.09
0.90
2.2
1.2
—
—
—
0
0
6
29
2.09
0.90
2.2
1.8
—
—
—
0
0
13
81
1.63
0.82
1.1
1.5
—
—
—
0
0
6
32
1.89
0.82
1.2
1.5
—
—
—
0
0
6
33
1.84
0.79
1.3
1.5
—
—
—
0
0
6
33
1.84
0.79
1.3
1.5
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
6
106
0.56
0.74
2.5
4.3
39.43
30.70
mg/l
—
6
91
5
25
2.02
0.73
1.4
1.5
0.28
0.51
mmol/l
—
5
25
5
26
1.94
0.71
2.4
1.9
—
—
—
0
0
9
59
1.54
0.69
3.0
1.5
—
—
—
0
0
5
27
1.87
0.68
1.4
1.7
—
—
—
0
0
5
27
1.87
0.68
1.4
1.7
—
—
—
0
0
5
27
1.87
0.68
1.4
1.7
—
—
—
0
0
5
27
1.87
0.68
1.4
1.3
—
—
—
0
0
36
287
1.29
0.68
3.6
3.5
—
—
—
0
0
5
28
1.80
0.66
1.6
1.3
—
—
—
0
0
21
155
1.38
0.65
1.3
1.2
7.67
125.25
u/ml
—
6
59
71
616
1.20
0.64
3.0
2.9
2.45
2.46
mmol/l
0.25
62
554
70
608
1.20
0.63
2.8
1.7
0.88
1.41
mg/l
1.82
58
476
8
49
1.65
0.62
1.3
1.4
—
—
—
0
0
8
49
1.65
0.62
1.3
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
19
251
0.74
0.58
3.4
2.7
4.66
4.33
kpa
0.25
19
243
11
160
0.68
0.57
2.5
2.4
1.13
1.16
%
0.07
11
160
56
481
1.20
0.57
2.4
1.9
—
—
—
0
0
10
147
0.67
0.55
1.6
1.3
—
—
—
0
0
9
60
1.52
0.55
1.0
1.1
—
5.46
—
0
8
6
38
1.59
0.54
1.2
1.2
0.80
0.52
nmol/l
—
6
33
96
1056
0.86
0.54
4.4
4.1
0.03
0.02
estimate
0.14
30
241
11
156
0.69
0.51
2.5
2.4
0.48
0.62
%
1.04
11
156
169
1595
1.14
0.51
6.0
5.2
6.45
6.67
mmol/l
0.83
163
1520
7
106
0.65
0.49
2.4
4.3
55.04
114.58
mg/l
—
7
90
11
77
1.45
0.46
2.5
1.5
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
8
56
1.44
0.43
1.0
1.2
3.70
3.78
mmol/l
—
8
51
5
32
1.57
0.42
1.4
1.5
—
—
—
0
0
5
32
1.57
0.42
4.4
3.6
5.54
3.33
nmol/l
—
5
32
5
32
1.57
0.42
1.4
1.5
—
—
—
0
0
5
33
1.52
0.41
1.4
1.5
—
—
—
0
0
13
97
1.36
0.40
3.8
1.6
4.66
8.55
iu/ml
—
5
20
61
546
1.15
0.39
5.2
4.2
414.62
246.59
ng/l
0.30
53
456
101
936
1.12
0.38
3.2
3.3
2077.53
1308.13
ng/l
0.82
86
791
9
67
1.35
0.38
3.1
1.5
—
—
—
0
0
6
42
1.44
0.35
1.8
1.6
—
—
—
0
0
149
1418
1.10
0.34
4.5
4.1
33.23
5.49
estimate
0.38
39
296
73
794
0.89
0.34
5.4
4.3
0.00
0.01
estimate
0.50
34
261
155
1479
1.10
0.34
7.7
6.6
11.71
11.51
umol/l
0.05
146
1408
81
875
0.90
0.33
3.5
3.1
28.35
31.55
u/l
0.99
75
824
19
155
1.24
0.33
1.8
1.9
—
—
—
0
0
147
1404
1.10
0.30
4.5
4.1
0.00
0.00
estimate
-0.00
36
289
14
111
1.27
0.30
1.5
1.8
1.81
3.74
ug/l
0.32
14
101
8
65
1.24
0.27
1.5
1.2
—
—
—
0
0
8
66
1.22
0.27
1.9
1.1
1.01
0.86
g/l
—
8
66
149
1430
1.09
0.27
4.4
4.2
0.00
0.01
estimate
0.50
38
271
55
507
1.10
0.24
2.0
1.7
1082.42
1218.43
nmol/l
0.60
34
375
11
88
1.26
0.23
9.1
2.2
2.10
1.57
mg/l
0.91
11
73
64
597
1.09
0.22
1.3
1.2
0.85
1.36
u/ml
0.79
19
155
5
41
1.22
0.22
1.6
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
167.12
—
0
12
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
37
337
1.11
0.20
11.4
8.9
2.15
0.72
mmol/l
1.11
29
282
98
935
1.07
0.20
5.4
3.8
8.66
8.19
mg/mmol
0.04
54
576
24
269
0.88
0.19
2.1
2.6
32.32
32.22
u/l
0.01
19
223
60
563
1.08
0.18
2.0
1.8
435.30
25161741.42
pmol/l
0.50
41
465
10
82
1.23
0.17
1.0
1.7
—
—
—
0
0
7
63
1.11
0.17
1.7
1.1
1.47
1.59
g/l
—
7
63
8
69
1.16
0.16
1.8
1.3
—
8.26
—
0
14
19
171
1.12
0.13
2.1
2.0
—
—
—
0
0
79
763
1.05
0.11
3.3
3.6
0.00
0.00
estimate
-0.00
30
229
20
217
0.92
0.09
1.7
1.4
—
—
—
0
0
30
282
1.07
0.09
2.8
3.3
2.47
1.84
mmol/l
0.40
25
239
21
194
1.09
0.09
1.9
2.2
3.31
3.36
ratio
0.09
15
162
6
55
1.09
0.09
1.8
1.6
—
—
—
0
0
6
56
1.07
0.08
1.7
3.9
20.33
29.40
u/ml
—
6
56
5
64
0.78
0.08
1.2
1.4
—
—
—
0
0
7
64
1.10
0.08
3.3
1.3
—
—
—
0
0
7
68
1.03
0.08
2.3
1.9
—
—
—
0
0
9
84
1.07
0.07
1.2
1.1
—
—
—
0
0
13
118
1.11
0.07
1.0
1.0
—
—
—
0
0
9
85
1.06
0.07
1.2
1.1
—
—
—
0
0
33
346
0.95
0.07
2.5
2.0
—
—
—
0
0
19
203
0.93
0.06
4.5
2.8
46.00
63.89
ml/min/173m2
1.26
12
83
20
213
0.93
0.06
1.5
1.6
—
—
—
0
0
35
363
0.96
0.05
1.7
1.5
—
—
—
0
0
38
367
1.04
0.05
2.4
1.9
—
—
—
0
0
32
332
0.96
0.04
3.8
4.5
3.50
27.94
ug/l
1.03
21
282
89
876
1.02
0.04
3.5
2.5
56.14
68.60
u/l
0.88
78
809
199
1979
1.02
0.02
26.7
23.4
331.50
331.29
g/l
0.12
199
1972
15
158
0.95
0.02
1.1
1.2
353.18
300.48
u/ml
0.06
15
147
13
123
1.06
0.01
1.7
1.3
—
—
—
0
0
109
1097
0.99
0.01
3.8
4.2
26.23
42.41
ng/l
1.38
81
824
29
288
1.01
0.00
2.9
3.4
6.32
5.74
kpa
1.39
29
281
31
313
0.99
0.00
2.4
2.7
11.70
10.00
umol/l
0.17
26
280
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
95
0.95
-0.00
1.4
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.23
—
0
6
8
82
0.97
-0.00
2.6
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.57
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
9
90
1.00
-0.00
1.1
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_UPPERLIMB – Melanoma in situ of upper limb, including shoulder
GWS hits: 1
This endpoint is excluded from FinRegistry analyses (omitted endpoint).